Provision of dietetic care in CF centres in the UK  by Morton, A. et al.
11. Nutrition S89
355 Provision of dietetic care in CF centres in the UK
A. Morton1, S. Wolfe1, R. Barnes2. 1Regional CF Unit, Leeds, United Kingdom;
2CF Trust, Bromley, United Kingdom
Introduction: Centre care has been associated with improved outcomes for people
with CF. In 2006 the CF Trust introduced peer reviews of UK CF centres, with
the aims of providing equity of service provision and improved quality of care
for patients. These reviews have recognised a wide variation in dietetic service
provision. In 2008 a questionnaire was sent to dietitians working in specialist centres
to determine the availability of specialist dietetic support.
Methods: Questionnaires were sent to 46 adult (A) and paediatric (P) CF centres,
all treating over 50 patients. Data regarding dietetic stafﬁng levels and service
provision are reported.
Results: 32 (70%) questionnaires were returned (19 A, 13 P). Stafﬁng levels varied.
Adult: median 0.33 whole time equivalent (WTE) dietitians/50 total (full and shared
care) patients (range 0.08−0.91). Paediatric: median 0.18 WTE/50 total patients
(range 0.09−0.36). Shared care arrangements were offered by 7 A and 12 P centres.
Despite shared care not being a recognised model of adult CF care in the UK, 37%
of adult centres were providing some form of shared care. 229 (7%) of A patients
and 1327 (54%) of P patients received shared care. There were a number of shared
care models. The CF Trust recommends stafﬁng levels of 0.4 WTE/50 full care
patients plus 0.2 WTE/50 shared care patients. When considering these two levels
of stafﬁng, 63% of A and 85% of P centres were under staffed with P centres being
more severely under resourced.
Conclusion: The results indicate that dietetic stafﬁng levels often do not meet
recognised standards. The results also highlight the larger numbers of shared care
patients in P centres, and despite recommendations to the contrary, many adults
are receiving some form of shared care. The different models for shared care may
impact on dietetic resources.
356 Improvement of intestinal comfort in cystic ﬁbrosis patients after
probiotics consumption
R. del Campo1,2, M. Garriga2, J. Agrimbau2, A. Lamas2, L. Maiz2, R. Canton1,2,
L. Suarez2. 1Service of Microbiology, Hospital Ramo´n y Cajal, Madrid, Spain;
2Cystic Fibrosis Unit, Hospital Ramo´n y Cajal, Madrid, Spain
Objective: To determine if probiotic consumption improve the intestinal health of
cystic ﬁbrosis (CF) patients.
Patients and Methods: Forty CF-patients (22 male and 18 female) were included
divided into paediatric (mean age 12.2 years, range 4−17) and adults (mean age
27.7, range 20−44). A randomized protocol assigned correlatively the patients in two
different groups: Group A consumed 1 capsule/day of CasenBiotic, (CasenFleet),
and group B consumed 2 package/day of VLS3 (Faes Farma). All groups consumed
probiotics during six months. Two different inquiries (GIQLY to measure the
intestinal comfort, and SFH-12 to calculate the general status of health) were
realized in two different times: Initial time (Before probiotic consumption) and
Final time (At the end of the 6 months). The ANCOVA multifactorial test were
used to analyzed the statistical signiﬁcance of differences.
Results: Both types of probiotics were well-tolerated for all patients, although
the CasenBiotic were the most valued for the patients. Taking account the SF-12
inquiry, signiﬁcant differences between the basal and the ﬁnal times, even tough
between the groups A or B, were not observed. When we considered the GIQLY
test, statistical differences (p = 0.01) were obtained between the initial and the ﬁnal
points. These results were identical for both groups of probiotics, without difference
between them.
Conclusions: Probiotics improved the intestinal comfort in CF-patients, increasing
also the LAB density. Even though more studies is needed, probiotics should be
considered as a regular supplement in this type of patients.
